Macrogol Plus Elektrolyte Beta

Macrogol 3350, the active ingredient in Macrogol Plus Elektrolyte Beta, is an osmotic laxative presented as an oral powder for solution for oral use. It is used to relieve constipation and to provide electrolyte balance in patients requiring fluid replacement.

GNH USA supplies Macrogol Plus Elektrolyte Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics and comprehensive technical support.

Macrogol Plus Elektrolyte Beta is an osmotic laxative that acts on the gastrointestinal tract to alleviate constipation and restore electrolyte balance. - Constipation: softens stool and promotes regular bowel movements in adults and children with functional constipation. - Bowel preparation: facilitates intestinal cleansing before diagnostic procedures such as colonoscopy. - Electrolyte replacement: supplies sodium, potassium and chloride to patients experiencing fluid loss from diarrhea or vomiting.

Macrogol Plus Elektrolyte Beta may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas causing discomfort. - Nausea: mild feeling of queasiness. - Diarrhea: loose stools occurring if dose is excessive. - Electrolyte imbalance: mild changes in serum sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte disturbances: significant hyponatremia or hyperkalemia. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing Macrogol Plus Elektrolyte Beta, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: adjust use in patients with impaired kidney function due to altered electrolyte handling. - Monitor electrolytes: check serum sodium, potassium and chloride during prolonged therapy. - Avoid in intestinal obstruction: the product can worsen blockage. - Use with caution in elderly: increased susceptibility to dehydration. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Store at ambient temperature: keep below 25 °C, protect from moisture and keep in original container.

Macrogol Plus Elektrolyte Beta can interact with other medicines, influencing their absorption or electrolyte balance.

Major Interactions (Avoid): - Absorbed oral medications: co‑administration may reduce absorption of drugs such as digoxin, lithium, and certain antibiotics; separate dosing by at least 2 hours. - Intravenous electrolyte solutions: concurrent high‑dose IV electrolytes may cause excess sodium or potassium levels; avoid simultaneous use.

Moderate Interactions (Monitor Closely): - Antidiarrheal agents: agents like loperamide may counteract the laxative effect; monitor bowel response. - Diuretics: may increase risk of electrolyte disturbances; monitor serum electrolytes. - Renin‑angiotensin system inhibitors: potential for additive potassium changes; observe potassium levels.